Merck | MRK - Gross Profit On Sales

Stock Price
117.75
Daily Change
0.40 0.34%
Monthly
0.17%
Yearly
2.39%
Q2 Forecast
114.30

Merck reported EUR3.07B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Adidas EUR 3.37B 281M Mar/2026
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.69B 175M Mar/2026
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 212M 276M Dec/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Infineon EUR 1.48B 15M Mar/2026
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Linde USD 3.27B 969M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 3.19B 621M Dec/2025